2244 related articles for article (PubMed ID: 25886172)
1. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
4. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
5. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment.
Benhadou F; Dirix V; Domont F; Willaert F; Van Praet A; Locht C; Mascart F; Corbière V
Front Immunol; 2021; 12():672894. PubMed ID: 34149708
[TBL] [Abstract][Full Text] [Related]
7. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
8. A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y; Joo H; Cho SN
Yonsei Med J; 2019 Apr; 60(4):375-380. PubMed ID: 30900424
[TBL] [Abstract][Full Text] [Related]
9. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
[TBL] [Abstract][Full Text] [Related]
11. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
Mathad JS; Bhosale R; Balasubramanian U; Kanade S; Mave V; Suryavanshi N; Gupte N; Joshi S; Chandanwale A; Dupnik KM; Kulkarni V; Deshpande P; Fitzgerald DW; Gupta A
Am J Respir Crit Care Med; 2016 Jun; 193(12):1421-8. PubMed ID: 26765255
[TBL] [Abstract][Full Text] [Related]
12. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
[TBL] [Abstract][Full Text] [Related]
13. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
14. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
15. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.
Lagrange PH; Thangaraj SK; Dayal R; Deshpande A; Ganguly NK; Girardi E; Joshi B; Katoch K; Katoch VM; Kumar M; Lakshmi V; Leportier M; Longuet C; Malladi SV; Mukerjee D; Nair D; Raja A; Raman B; Rodrigues C; Sharma P; Singh A; Singh S; Sodha A; Kabeer BS; Vernet G; Goletti D
PLoS One; 2013; 8(9):e73579. PubMed ID: 24039990
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
[TBL] [Abstract][Full Text] [Related]
17. Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
Dirix V; Schepers K; Massinga-Loembe M; Worodria W; Colebunders R; Singh M; Locht C; Kestens L; Mascart F;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):344-52. PubMed ID: 27306506
[TBL] [Abstract][Full Text] [Related]
18. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
19. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; Horne DJ; John-Stewart G
J Acquir Immune Defic Syndr; 2017 May; 75(1):128-136. PubMed ID: 28141782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
